22 abril 2009

Aplidin en Combinacion del Cytarabine ( ARA C ) De Pzifer . Se da por Terminada la Fase I-II en Relapsed/Refractory Leukemia .

Clinical Study of Plitidepsin (Aplidin®) in Combination With Cytarabine in Patients With Relapsed/Refractory Leukemia .

This study has been terminated.
( Poor recruitment )
First Received: October 24, 2008 Last Updated: April 20, 2009 History of Changes
Sponsored by: PharmaMar

Information provided by: PharmaMar
ClinicalTrials.gov Identifier: NCT00780143